Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)

Download

Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity.

Cancer Type: Lung Cancer

GPL: 97

Number of Genes with Data: 279

Number Observations: 18

Number Outputs: 1

Imbalanced Ratio: 0.636363636

Default Task: Classification